GE Healthcare and CorTechs Labs Inc. Announce Strategic Agreement to Co-Market NeuroQuant(R), Comprehensive Solutions for Quantifying Brain Volume Loss

Advanced magnetic resonance imaging (MRI) solutions combined with the innovative NeuroQuant software provides invaluable information to neurologists and radiologists

Mazor Robotics Announces World´s First Renaissance(R) Asleep Deep Brain Stimulation Procedure

-- (Healthcare Sales & Marketing Network) -- Mazor Robotics, Ltd. (TASE: MZOR; NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced that for the first time ever, a surgeon utilized Mazor Robotics Renaissance Guidance System to perform an Asleep Deep Brain Stimulation (DBS) procedure earlier this month at Littleton Adventist Hospital in Littleton, Colo.

Mazor Robotics to Launch and Demo New Renaissance(R) Brain Module at American Association of Neurological Surgeons (AANS) Annual Meeting in San Francisco

ORLANDO, Fla.--(Healthcare Sales & Marketing Network)--On April 7, 2014, Mazor Robotics (TASE:MZOR; NASDAQ GM:MZOR) will debut and officially launch the new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS) annual meeting. The Renaissance system is FDA-cleared for both spine and brain surgery.

Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans

PLAINSBORO, N.J., April 4, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced that the Camino(R) Flex Ventricular Catheter has received clearance from the United States Food and Drug Administration (FDA) for use with magnetic resonance imaging (MRI). The Camino Flex Ventricular Catheter is an advanced, tunneled ventricular catheter that is MR conditional at 1.5 and 3.0 T, with a sensor designed to measure directly at the source, and is used with Integra´s next-generation Camino(R) Monitor, which debuted in 2013. Integra is a leading provider of advanced intracranial pressure monitoring (ICP) systems. Over 800 centers in the United States use the Camino platform for conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and stroke.

Baxano Surgical Receives 510(k) Clearance for the Avance MIS Pedicle Screw System

RALEIGH, N.C., April 10, 2014 -- (Healthcare Sales & Marketing Network) -- Baxano Surgical, Inc. (BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that it has received U.S. Food and Drug Administration 510(k) clearance (k133743) of its Avance(TM) MIS Pedicle Screw System, which may be used as an adjunct to fusion in numerous degenerative and complex spinal pathologies. The innovative design of Avance provides a quick and easy-to-use, percutaneous pedicle screw system that addresses single, complex and multi-level spinal pathologies with minimal tissue disruption and trauma. The Avance system will be in limited market release in the second and third quarter of 2014 and is planned for full launch in the fourth quarter of 2014.

Medicrea Announces European Launch of UNiD, the World´s First Patient-Specific Spinal Rod

LYON, France--(Healthcare Sales & Marketing Network)--The MEDICREA group (ALMED.PA) (Alternext Paris: FR0004178572-ALMED), a company that specializes in the development of innovative surgical technologies for the treatment of spinal pathologies, today announced the European launch of the UNiD, the world´s first patient-specific spinal osteosynthesis rod system.

Reverse Medical(R) Corporation Announces FDA IDE Approval for the BARREL(R) Vascular Reconstruction Device for the Treatment of Intracranial Bifurcation Aneurysms

IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Reverse Medical® Corporation today announced FDA IDE approval for clinical investigation of their BARREL® Vascular Reconstruction Device (VRD). The BARREL® Vascular Reconstruction Device is designed for use with occlusive devices in the treatment of intracranial bifurcation aneurysms.

Neurosurgery journal published study reinforces value of high-field iMRI

VISIUS intraoperative MRI significantly enhances amount of complete resection in brain tumors and leads to better patient outcomes.

RTI Surgical(TM) Announces Launch of Streamline(R) OCT System

ALACHUA, Fla.--(Healthcare Sales & Marketing Network)--RTI Surgical Inc. (RTI) (RTIX), a leading global surgical implant company, announced today the full market launch of the Streamline® OCT System. The system is designed to promote fusion of the occipto-cervico-thoracic spine (or occiput-T3). RTI received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the system in March 2014.

GS Medical USA Announces FDA Clearance and Launch of AnyPlus(R) T/PLIF Cage

FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea

MINNEAPOLIS, May 1, 2014 -- (Healthcare Sales & Marketing Network) -- Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.

Cooling system may have neuroprotective effects in acute stroke

A poster presented at the European Stroke Conference (6–9 May 2014, Nice, France) by Robbert-Jan van Hooff (Department of Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium) and colleagues reports that surface cooling of the neck with a surface cooling system could contribute to therapeutic hypothermia and neuroprotective effects in acute stroke.

New MRI CryoProbe delivers highest sensitivity in rat brain in vivo imaging

At the joint ISMRM-ESMRMB 2014 meeting (10–16 May, Milan, Italy), Bruker announced a new phased array MRI CryoProbe for in vivo neuroimaging that delivers unparalleled access to rat brain microstructure and biochemistry, previously unresolvable in in vivo imaging of the rat. The sensitivity increase by up to a factor of 2.4 allows researchers to reduce imaging times by a factor of 5, or to increase spatial resolution.

NeuroVascular Quality Initiative launches first procedure module: Acute Ischaemic Stroke

The Society of NeuroInterventional Surgery and M2S announced the launch of the NeuroVascular Quality Initiative, a multi-module registry system designed to track performance and outcomes data across a variety of neurovascular conditions. The launch debuts the Acute Ischaemic Stroke module, which will be used to track and benchmark clinical performance at the centre level and nationally, providing valuable insight into the effectiveness of endovascular interventions and associated devices in treating a condition known to be the nation’s fourth leading cause of death. The NeuroVascular Quality Initiative is now officially enrolling hospitals and specialists in the Acute Ischaemic Stroke module.

Study reinforces value of high-field iMRI in brain tumour resection

IMRIS has announced that a study published in the journal Neurosurgery by the neurosurgical team at Cleveland Clinic (USA) adds to growing clinical evidence which validates use of high-field intraoperative MRI (iMRI) as an effective tool for maximising the amount of surgical resection of gliomas (brain tumours).